Testing how your brain responds to carbon dioxide in epilepsy
Part of Brain & nervous system clinical trials.
This study measures how sensitive your brain is to higher carbon dioxide levels to learn more about sudden unexpected death in epilepsy (SUDEP). You may be invited because you have epilepsy and are having evaluation at a specialized epilepsy unit or clinic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 99 years old
- You have confirmed or suspected epilepsy
- You will either be admitted to the epilepsy monitoring unit (EMU) or seen at the University of Iowa epilepsy clinic
- You do not have serious, uncontrolled heart, lung, or liver problems
- You are not using opioid medicines
- If you can become pregnant, you are not pregnant and use highly effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research studies how the brain controls breathing in people with drug-resistant epilepsy. Researchers use special electrodes placed in your brain during surgery to map these connections and better understand seizures.
This study looks at how epilepsy affects a chemical in the brainstem that helps control breathing and alertness. It uses a special PET scan and breathing tests to measure this in people with hard-to-control seizures.
This study looks at breathing problems during seizures in people with drug-resistant focal epilepsy. It aims to understand why some people stop breathing or have low oxygen during seizures, which could help prevent sudden death in epilepsy.
This study tests a wearable device that monitors your body position during seizures. The goal is to see if it can warn about dangerous positions that may lead to sudden unexpected death in epilepsy (SUDEP), a rare but serious risk.
This study tests whether a medication called trospium chloride (often used for bladder problems) can improve memory and brain activity in people with epilepsy. Participants will receive the drug while undergoing brain monitoring for their epilepsy, and researchers will measure brain signals to see if it helps.
This study looks at what factors may be linked to sudden, unexplained death in people with epilepsy. Your family’s willingness to participate matters, because the researchers compare cases of sudden unexplained death to people with epilepsy who have not had it.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.